U.S. markets close in 5 hours 12 minutes
  • S&P 500

    +102.68 (+2.79%)
  • Dow 30

    +717.31 (+2.43%)
  • Nasdaq

    +364.98 (+3.37%)
  • Russell 2000

    +51.32 (+3.00%)
  • Crude Oil

    +1.75 (+2.09%)
  • Gold

    +25.20 (+1.48%)
  • Silver

    +0.50 (+2.41%)

    +0.0118 (+1.20%)
  • 10-Yr Bond

    -0.0580 (-1.59%)

    +0.0082 (+0.72%)

    -0.1330 (-0.09%)

    +690.85 (+3.56%)
  • CMC Crypto 200

    +10.47 (+2.35%)
  • FTSE 100

    +158.23 (+2.29%)
  • Nikkei 225

    +776.42 (+2.96%)

Chimera Investment Sees Hammer Chart Pattern: Time to Buy?

Chimera Investment Corporation CIM has been struggling lately, but the selling pressure may be coming to an end soon. That is because CIM recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.

What is a Hammer Chart Pattern?

A hammer chart pattern is a popular technical indicator that is used in candlestick charting. The hammer appears when a stock tumbles during the day, but then finds strength at some point in the session to close near or above its opening price. This forms a candlestick that resembles a hammer, and it can suggest that the market has found a low point in the stock, and that better days are ahead.

Other Factors

Plus, earnings estimates have been rising for this company, even despite the sluggish trading lately. In just the past 60 days alone 1 estimate has gone higher, compared to none lower, while the consensus estimate has also moved in the right direction.

Estimates have actually risen so much that the stock now has a Zacks Rank #1 (Strong Buy) suggesting this relatively unloved stock could be due for a breakout soon. This will be especially true if CIM stock can build momentum from here and find a way to continue higher of off this encouraging trading development. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Chimera Investment Corporation (CIM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research